• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Streptococcal Infections Drug Pipeline Capsule - 2012 Update Product Image

Global Streptococcal Infections Drug Pipeline Capsule - 2012 Update

  • Published: September 2012
  • Region: Global
  • 18 pages
  • Fore Pharma

Fore Pharma's latest report 'Global Streptococcal Infections Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Streptococcal Infections market. It covers active Streptococcal Infections pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Key Features of the Report:
- Streptococcal Infections: Overview
- Streptococcal Infections Pipeline Overview
- Streptococcal Infections Phase 3 Clinical Trial Pipeline Insights
- Streptococcal Infections Phase 2 Clinical Trial Pipeline Insights
- READ MORE >

1. Streptococcal Infections - Disease Overview
2. Streptococcal Infections Pipeline Overview
3. Streptococcal Infections Phase 3 Clinical Trial Pipeline Insights
4. Streptococcal Infections Phase 2 Clinical Trial Pipeline Insights
5. Streptococcal Infections Phase 1 Clinical Trial Pipeline Insights
6. Streptococcal Infections Preclinical Research Pipeline Insights
7. Streptococcal Infections Discovery Stage Pipeline Insights
8. Streptococcal Infections Drug Development Activities - Geographic Landscape
8.1. Streptococcal Infections R&D Activities in North America
8.2. Streptococcal Infections R&D Activities in Europe
9. Streptococcal Infections Pipeline - Licensing Activities
Table 1. Streptococcal Infections Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Streptococcal Infections Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Streptococcal Infections Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Streptococcal Infections Pipeline Molecules - Preclinical Research
Table 5. Streptococcal Infections Pipeline Molecules - Drug Discovery
Table 6. Streptococcal Infections R&D Activities by Geography
Table 7. Streptococcal Infections Pipeline Molecules - North America
Table 8. Streptococcal Infections Pipeline Molecules - Europe
Table 9. Streptococcal Infections Pipeline - Licensing Activities

Figure 1. Streptococcal Infections Pipeline Molecules by R&D Stage
Figure 2. Streptococcal Infections R&D Activities by Geography

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos